BIOTECHNOLOGY VALUE FUND L P 13D/13G Filings for SpringWorks Therapeutics, Inc. (SWTX)

BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for SpringWorks Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2021-02-11
5:16 pm
Sale		 2020-12-31 13G SpringWorks Therapeutics, Inc.
SWTX		 BIOTECHNOLOGY VALUE FUND L P 50
1.000%		 -3,079,105decrease
(-100.00%)		 Filing